Biocon, India's top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business, its Chairman and Managing Director said on Wednesday.
first published: Jan 25, 2012 11:02 am
A collection of the most-viewed Moneycontrol videos.
Live: Nifty extends gain to 3rd day led by IT stocks; India VIX cools 16% in 3 days | Closing Bell
Stocks Gains on Wall St despite elevated oil prices | Fed expected to leave rates unchanged
Live: Nifty adds 400 points, Sensex up 1,400 points in 2 days; India VIX cools | Closing Bell
Relief Rally in Global Markets 🌍 | Oil Cools, Hormuz Tensions | Nifty 23,500 in Focus | Opening Bell
